Focus forming assays (FFAs) were performed as previously described [50]. Briefly, Vero E6 cells were seeded in 96-well plates to be 100% confluent. Samples were serially diluted in serum-free media and 20 μl was used to infect cells. Cells were incubated for 45 min at 37°C with 5% CO2 before 0.85% methylcellulose overlay was added. Cells were incubated for 24 h at 37°C with 5% CO2. After incubation, overlay was removed, and cells were washed three times with PBS before fixed and virus inactivated by 10% formalin for 30 min at room temperature. Cells were then permeabilized and blocked with 0.1% saponin/0.1% BSA in PBS before incubated with α-SARS-CoV-2 Nucleocapsid primary antibody (Cell Signaling Technology) at 1:1000 in permeabilization/blocking buffer overnight at 4°C. Cells were then washed (3x) with PBS before incubated with Alexa Fluor™ 555-conjugated α-mouse secondary antibody (Invitrogen #A28180) at 1:2000 in permeabilization/blocking buffer for 1 h at room temperature. Cells were washed (3X) with PBS. Fluorescent foci images were captured using a Cytation 7 cell imaging multi-mode reader (BioTek), and foci were counted manually.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.